Page last updated: 2024-08-22

phenethyl isothiocyanate and Neoplasms, Pleural

phenethyl isothiocyanate has been researched along with Neoplasms, Pleural in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanquart, C; Cellerin, L; Denis, I; Gregoire, M	1

Other Studies

1 other study(ies) available for phenethyl isothiocyanate and Neoplasms, Pleural

Article	Year
Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma. Oncotarget, 2014, Nov-30, Volume: 5, Issue:22 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Cisplatin; Coculture Techniques; DNA Damage; Drug Resistance, Neoplasm; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Isothiocyanates; Macrophages; Mesothelioma; Phosphorylation; Pleural Neoplasms; Prognosis; Reactive Oxygen Species; Tumor Cells, Cultured	2014

Article

Year

Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma.

Oncotarget, 2014, Nov-30, Volume: 5, Issue:22

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Cisplatin; Coculture Techniques; DNA Damage; Drug Resistance, Neoplasm; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Isothiocyanates; Macrophages; Mesothelioma; Phosphorylation; Pleural Neoplasms; Prognosis; Reactive Oxygen Species; Tumor Cells, Cultured

2014